Inovio Pharmaceuticals Inc (NYSEMKT:INO) average recommendation is buy with average target price of $3.50. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $3.40 in last trading session, and closed at $3.72, trading in the range of $3.38 – $3.95. The stock showed a positive weekly performance of 35.27%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it will present at the Cowen and Company 34th Annual Health Care Conference being held in Boston. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business on Tuesday, March 4, at 10:40 a.m. (ET). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares closed at $8.63 on last trade day, by decreasing -2.71%. Stock 52 week range is $2.15 – $23.00. Company’s market capitalization is $1.60 billion.
Shares of MannKind Corp. (NASDAQ:MNKD) saw unusually large options trading activity on Monday. Stock traders acquired 12,443 call options on the stock, Stock Ratings Network reports. This is an increase of approximately 120% compared to the average daily volume of 5,661 call options. MannKind Corporation (NASDAQ:MNKD) stock advanced 6.31% and finished the last session at $6.40. The EPS of the stock remained -0.59. Company’s market capitalization is $2.36 billion.
Gilead Sciences (NASDAQ:GILD)‘s stock had its “buy” rating restated by investment analysts at TheStreet in a note issued to investors on Monday, AnalystRatings.Net reports. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened at $82.99 in last trading session and closed at $83.57. The 52 week range of the stock is $41.60 – $84.40 and the day range was $82.80 – $84.06.
Leave a Reply